{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T02:52:02Z","timestamp":1794711122277,"version":"4.9.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T00:00:00Z","timestamp":1669680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T00:00:00Z","timestamp":1669680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["819775"],"award-info":[{"award-number":["819775"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["RETOS2019-107332RB-I00"],"award-info":[{"award-number":["RETOS2019-107332RB-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Basic Res Cardiol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Aortic stenosis (AS) is associated with left ventricular (LV) hypertrophy and heart failure (HF). There is a lack of therapies able to prevent\/revert AS-induced HF. Beta3 adrenergic receptor (\u03b23AR) signaling is beneficial in several forms of HF. Here, we studied the potential beneficial effect of \u03b23AR overexpression on AS-induced HF. Selective \u03b23AR stimulation had a positive inotropic effect. Transgenic mice constitutively overexpressing human \u03b23AR in the heart (c-h\u03b23tg) were protected from the development of HF in response to induced AS, and against cardiomyocyte mitochondrial dysfunction (fragmented mitochondria with remodeled cristae and metabolic reprogramming featuring altered substrate use). Similar beneficial effects were observed in wild-type mice inoculated with adeno-associated virus (AAV9) inducing cardiac-specific overexpression of human \u03b23AR before AS induction. Moreover, AAV9-h\u03b23AR injection into wild-type mice at late disease stages, when cardiac hypertrophy and metabolic reprogramming are already advanced, reversed the HF phenotype and restored balanced mitochondrial dynamics, demonstrating the potential of gene-therapy-mediated \u03b23AR overexpression in AS. Mice with cardiac specific ablation of <jats:italic>Yme1l<\/jats:italic> (cYKO), characterized by fragmented mitochondria, showed an increased mortality upon AS challenge. AAV9-h\u03b23AR injection in these mice before AS induction reverted the fragmented mitochondria phenotype and rescued them from death. In conclusion, our results step out that \u03b23AR overexpression might have translational potential as a therapeutic strategy in AS\u2013induced HF.<\/jats:p>","DOI":"10.1007\/s00395-022-00966-z","type":"journal-article","created":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T07:30:29Z","timestamp":1669707029000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Beta-3 adrenergic receptor overexpression reverses aortic stenosis\u2013induced heart failure and restores balanced mitochondrial dynamics"],"prefix":"10.1007","volume":"117","author":[{"given":"Andr\u00e9s","family":"Pun-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agust\u00edn","family":"Clemente-Morag\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocio","family":"Villena-Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sanz-Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anabel","family":"D\u00edaz-Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bel\u00e9n","family":"Prados","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferm\u00ed","family":"Mont\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Dolores","family":"Ivorra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"M\u00e1rquez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Cannavo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan A.","family":"Bernal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter J.","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Fuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"de la Pompa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5036-254X","authenticated-orcid":false,"given":"Borja","family":"Ibanez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,29]]},"reference":[{"key":"966_CR1","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1016\/j.jacc.2011.09.033","volume":"58","author":"JP Aragon","year":"2011","unstructured":"Aragon JP, Condit ME, Bhushan S, Predmore BL, Patel SS, Grinsfelder DB, Gundewar S, Jha S, Calvert JW, Barouch LA, Lavu M, Wright HM, Lefer DJ (2011) Beta3-adrenoreceptor stimulation ameliorates myocardial ischemia-reperfusion injury via endothelial nitric oxide synthase and neuronal nitric oxide synthase activation. J Am Coll Cardiol 58:2683\u20132691. https:\/\/doi.org\/10.1016\/j.jacc.2011.09.033","journal-title":"J Am Coll Cardiol"},{"key":"966_CR2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/sj.bjp.0706048","volume":"144","author":"JG Baker","year":"2005","unstructured":"Baker JG (2005) The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors. Br J Pharmacol 144:317\u2013322. https:\/\/doi.org\/10.1038\/sj.bjp.0706048","journal-title":"Br J Pharmacol"},{"key":"966_CR3","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1002\/ejhf.784","volume":"19","author":"JL Balligand","year":"2017","unstructured":"Balligand JL (2017) Cardiac beta3-adrenergic receptors in the clinical arena: the end of the beginning. Eur J Heart Fail 19:576\u2013578. https:\/\/doi.org\/10.1002\/ejhf.784","journal-title":"Eur J Heart Fail"},{"key":"966_CR4","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1093\/cvr\/cvw056","volume":"111","author":"JL Balligand","year":"2016","unstructured":"Balligand JL (2016) Cardiac salvage by tweaking with beta-3-adrenergic receptors. Cardiovasc Res 111:128\u2013133. https:\/\/doi.org\/10.1093\/cvr\/cvw056","journal-title":"Cardiovasc Res"},{"key":"966_CR5","doi-asserted-by":"publisher","first-page":"E1244","DOI":"10.1152\/ajpendo.00600.2009","volume":"298","author":"G Barbatelli","year":"2010","unstructured":"Barbatelli G, Murano I, Madsen L, Hao Q, Jimenez M, Kristiansen K, Giacobino JP, De Matteis R, Cinti S (2010) The emergence of cold-induced brown adipocytes in mouse white fat depots is determined predominantly by white to brown adipocyte transdifferentiation. Am J Physiol Endocrinol Metab 298:E1244-1253. https:\/\/doi.org\/10.1152\/ajpendo.00600.2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"966_CR6","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1161\/CIRCULATIONAHA.113.004940","volume":"129","author":"C Belge","year":"2014","unstructured":"Belge C, Hammond J, Dubois-Deruy E, Manoury B, Hamelet J, Beauloye C, Markl A, Pouleur AC, Bertrand L, Esfahani H, Jnaoui K, Gotz KR, Nikolaev VO, Vanderper A, Herijgers P, Lobysheva I, Iaccarino G, Hilfiker-Kleiner D, Tavernier G, Langin D, Dessy C, Balligand JL (2014) Enhanced expression of beta3-adrenoceptors in cardiac myocytes attenuates neurohormone-induced hypertrophic remodeling through nitric oxide synthase. Circulation 129:451\u2013462. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.004940","journal-title":"Circulation"},{"key":"966_CR7","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1161\/CIRCULATIONAHA.115.014846","volume":"131","author":"RO Bonow","year":"2015","unstructured":"Bonow RO, Greenland P (2015) Population-wide trends in aortic stenosis incidence and outcomes. Circulation 131:969\u2013971. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.014846","journal-title":"Circulation"},{"key":"966_CR8","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/S0140-6736(16)00586-9","volume":"387","author":"RO Bonow","year":"2016","unstructured":"Bonow RO, Leon MB, Doshi D, Moat N (2016) Management strategies and future challenges for aortic valve disease. Lancet 387:1312\u20131323. https:\/\/doi.org\/10.1016\/S0140-6736(16)00586-9","journal-title":"Lancet"},{"key":"966_CR9","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/ejhf.714","volume":"19","author":"H Bundgaard","year":"2017","unstructured":"Bundgaard H, Axelsson A, Hartvig Thomsen J, Sorgaard M, Kofoed KF, Hasselbalch R, Fry NA, Valeur N, Boesgaard S, Gustafsson F, Kober L, Iversen K, Rasmussen HH (2017) The first-in-man randomized trial of a beta3 adrenoceptor agonist in chronic heart failure: the BEAT-HF trial. Eur J Heart Fail 19:566\u2013575. https:\/\/doi.org\/10.1002\/ejhf.714","journal-title":"Eur J Heart Fail"},{"key":"966_CR10","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.121.009120","volume":"15","author":"H Bundgaard","year":"2022","unstructured":"Bundgaard H, Axelsson Raja A, Iversen K, Valeur N, Tonder N, Schou M, Christensen AH, Bruun NE, Soholm H, Ghanizada M, Fry NAS, Hamilton EJ, Boesgaard S, Moller MB, Wolsk E, Rossing K, Kober L, Rasmussen HH, Vissing CR (2022) Hemodynamic effects of cyclic guanosine monophosphate-dependent signaling through beta3 adrenoceptor stimulation in patients with advanced heart failure: a randomized invasive Clinical Trial. Circ Heart Fail 15:e009120. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.121.009120","journal-title":"Circ Heart Fail"},{"key":"966_CR11","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1161\/CIRCULATIONAHA.110.964619","volume":"122","author":"H Bundgaard","year":"2010","unstructured":"Bundgaard H, Liu CC, Garcia A, Hamilton EJ, Huang Y, Chia KK, Hunyor SN, Figtree GA, Rasmussen HH (2010) beta(3) adrenergic stimulation of the cardiac Na+-K+ pump by reversal of an inhibitory oxidative modification. Circulation 122:2699\u20132708. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.964619","journal-title":"Circulation"},{"key":"966_CR12","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1161\/CIRCRESAHA.111.241117","volume":"108","author":"JW Calvert","year":"2011","unstructured":"Calvert JW, Condit ME, Aragon JP, Nicholson CK, Moody BF, Hood RL, Sindler AL, Gundewar S, Seals DR, Barouch LA, Lefer DJ (2011) Exercise protects against myocardial ischemia-reperfusion injury via stimulation of beta(3)-adrenergic receptors and increased nitric oxide signaling: role of nitrite and nitrosothiols. Circ Res 108:1448\u20131458. https:\/\/doi.org\/10.1161\/CIRCRESAHA.111.241117","journal-title":"Circ Res"},{"key":"966_CR13","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jacc.2017.05.020","volume":"70","author":"A Cannavo","year":"2017","unstructured":"Cannavo A, Rengo G, Liccardo D, Pun A, Gao E, George AJ, Gambino G, Rapacciuolo A, Leosco D, Ibanez B, Ferrara N, Paolocci N, Koch WJ (2017) beta1-Blockade prevents post-ischemic myocardial decompensation via beta3AR-dependent protective sphingosine-1 phosphate signaling. J Am Coll Cardiol 70:182\u2013192. https:\/\/doi.org\/10.1016\/j.jacc.2017.05.020","journal-title":"J Am Coll Cardiol"},{"key":"966_CR14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10741-018-9713-0","volume":"24","author":"L Chen","year":"2019","unstructured":"Chen L, Song J, Hu S (2019) Metabolic remodeling of substrate utilization during heart failure progression. Heart Fail Rev 24:143\u2013154. https:\/\/doi.org\/10.1007\/s10741-018-9713-0","journal-title":"Heart Fail Rev"},{"key":"966_CR15","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1093\/cvr\/cvm050","volume":"77","author":"AD Costa","year":"2008","unstructured":"Costa AD, Pierre SV, Cohen MV, Downey JM, Garlid KD (2008) cGMP signalling in pre- and post-conditioning: the role of mitochondria. Cardiovasc Res 77:344\u2013352. https:\/\/doi.org\/10.1093\/cvr\/cvm050","journal-title":"Cardiovasc Res"},{"key":"966_CR16","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.jacc.2015.01.045","volume":"65","author":"FM Cruz","year":"2015","unstructured":"Cruz FM, Sanz-Rosa D, Roche-Molina M, Garcia-Prieto J, Garcia-Ruiz JM, Pizarro G, Jimenez-Borreguero LJ, Torres M, Bernad A, Ruiz-Cabello J, Fuster V, Ibanez B, Bernal JA (2015) Exercise triggers ARVC phenotype in mice expressing a disease-causing mutated version of human plakophilin-2. J Am Coll Cardiol 65:1438\u20131450. https:\/\/doi.org\/10.1016\/j.jacc.2015.01.045","journal-title":"J Am Coll Cardiol"},{"key":"966_CR17","doi-asserted-by":"publisher","first-page":"6603","DOI":"10.1111\/febs.15706","volume":"288","author":"KA De Jong","year":"2021","unstructured":"De Jong KA, Nikolaev VO (2021) Multifaceted remodelling of cAMP microdomains driven by different aetiologies of heart failure. FEBS J 288:6603\u20136622. https:\/\/doi.org\/10.1111\/febs.15706","journal-title":"FEBS J"},{"key":"966_CR18","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1002\/ehf2.12648","volume":"7","author":"E Dubois-Deruy","year":"2020","unstructured":"Dubois-Deruy E, Gelinas R, Beauloye C, Esfahani H, Michel LYM, Dessy C, Bertrand L, Balligand JL (2020) Beta 3 adrenoreceptors protect from hypertrophic remodelling through AMP-activated protein kinase and autophagy. ESC Heart Fail 7:920\u2013932. https:\/\/doi.org\/10.1002\/ehf2.12648","journal-title":"ESC Heart Fail"},{"key":"966_CR19","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1126\/science.2570461","volume":"245","author":"LJ Emorine","year":"1989","unstructured":"Emorine LJ, Marullo S, Briend-Sutren MM, Patey G, Tate K, Delavier-Klutchko C, Strosberg AD (1989) Molecular characterization of the human beta 3-adrenergic receptor. Science 245:1118\u20131121. https:\/\/doi.org\/10.1126\/science.2570461","journal-title":"Science"},{"key":"966_CR20","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1097\/00029330-200712020-00018","volume":"120","author":"RT Gan","year":"2007","unstructured":"Gan RT, Li WM, Xiu CH, Shen JX, Wang X, Wu S, Kong YH (2007) Chronic blocking of beta 3-adrenoceptor ameliorates cardiac function in rat model of heart failure. Chin Med J (Engl) 120:2250\u20132255. https:\/\/doi.org\/10.1097\/00029330-200712020-00018","journal-title":"Chin Med J (Engl)"},{"key":"966_CR21","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s00395-014-0422-0","volume":"109","author":"J Garcia-Prieto","year":"2014","unstructured":"Garcia-Prieto J, Garcia-Ruiz JM, Sanz-Rosa D, Pun A, Garcia-Alvarez A, Davidson SM, Fernandez-Friera L, Nuno-Ayala M, Fernandez-Jimenez R, Bernal JA, Izquierdo-Garcia JL, Jimenez-Borreguero J, Pizarro G, Ruiz-Cabello J, Macaya C, Fuster V, Yellon DM, Ibanez B (2014) beta3 adrenergic receptor selective stimulation during ischemia\/reperfusion improves cardiac function in translational models through inhibition of mPTP opening in cardiomyocytes. Basic Res Cardiol 109:422. https:\/\/doi.org\/10.1007\/s00395-014-0422-0","journal-title":"Basic Res Cardiol"},{"key":"966_CR22","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1172\/JCI118823","volume":"98","author":"C Gauthier","year":"1996","unstructured":"Gauthier C, Tavernier G, Charpentier F, Langin D, Le Marec H (1996) Functional beta3-adrenoceptor in the human heart. J Clin Invest 98:556\u2013562. https:\/\/doi.org\/10.1172\/JCI118823","journal-title":"J Clin Invest"},{"key":"966_CR23","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1016\/j.jacc.2016.02.057","volume":"67","author":"P Genereux","year":"2016","unstructured":"Genereux P, Stone GW, O\u2019Gara PT, Marquis-Gravel G, Redfors B, Giustino G, Pibarot P, Bax JJ, Bonow RO, Leon MB (2016) Natural history, diagnostic approaches, and therapeutic strategies for patients with asymptomatic severe aortic stenosis. J Am Coll Cardiol 67:2263\u20132288. https:\/\/doi.org\/10.1016\/j.jacc.2016.02.057","journal-title":"J Am Coll Cardiol"},{"key":"966_CR24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/cvr\/cvv230","volume":"109","author":"KY Goh","year":"2016","unstructured":"Goh KY, Qu J, Hong H, Liu T, Dell\u2019Italia LJ, Wu Y, O\u2019Rourke B, Zhou L (2016) Impaired mitochondrial network excitability in failing guinea-pig cardiomyocytes. Cardiovasc Res 109:79\u201389. https:\/\/doi.org\/10.1093\/cvr\/cvv230","journal-title":"Cardiovasc Res"},{"key":"966_CR25","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1093\/cvr\/cvy052","volume":"114","author":"Y Guo","year":"2018","unstructured":"Guo Y, Wang Z, Qin X, Xu J, Hou Z, Yang H, Mao X, Xing W, Li X, Zhang X, Gao F (2018) Enhancing fatty acid utilization ameliorates mitochondrial fragmentation and cardiac dysfunction via rebalancing optic atrophy 1 processing in the failing heart. Cardiovasc Res 114:979\u2013991. https:\/\/doi.org\/10.1093\/cvr\/cvy052","journal-title":"Cardiovasc Res"},{"key":"966_CR26","doi-asserted-by":"publisher","first-page":"13956","DOI":"10.1016\/s0021-9258(18)80092-8","volume":"264","author":"JR Hadcock","year":"1989","unstructured":"Hadcock JR, Ros M, Malbon CC (1989) Agonist regulation of beta-adrenergic receptor mRNA. Analysis in S49 mouse lymphoma mutants. J Biol Chem 264:13956\u201313961. https:\/\/doi.org\/10.1016\/s0021-9258(18)80092-8","journal-title":"J Biol Chem"},{"key":"966_CR27","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1093\/eurheartj\/ehx366","volume":"39","author":"N Hermida","year":"2018","unstructured":"Hermida N, Michel L, Esfahani H, Dubois-Deruy E, Hammond J, Bouzin C, Markl A, Colin H, Steenbergen AV, De Meester C, Beauloye C, Horman S, Yin X, Mayr M, Balligand JL (2018) Cardiac myocyte beta3-adrenergic receptors prevent myocardial fibrosis by modulating oxidant stress-dependent paracrine signaling. Eur Heart J 39:888\u2013898. https:\/\/doi.org\/10.1093\/eurheartj\/ehx366","journal-title":"Eur Heart J"},{"key":"966_CR28","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1016\/j.jacc.2011.09.034","volume":"58","author":"G Heusch","year":"2011","unstructured":"Heusch G (2011) Beta3-adrenoceptor activation just says NO to myocardial reperfusion injury. J Am Coll Cardiol 58:2692\u20132694. https:\/\/doi.org\/10.1016\/j.jacc.2011.09.034","journal-title":"J Am Coll Cardiol"},{"key":"966_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00395-022-00909-8","volume":"117","author":"G Heusch","year":"2022","unstructured":"Heusch G (2022) Coronary blood flow in heart failure: cause, consequence and bystander. Basic Res Cardiol 117:1. https:\/\/doi.org\/10.1007\/s00395-022-00909-8","journal-title":"Basic Res Cardiol"},{"key":"966_CR30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00210-003-0860-y","volume":"369","author":"C Hoffmann","year":"2004","unstructured":"Hoffmann C, Leitz MR, Oberdorf-Maass S, Lohse MJ, Klotz KN (2004) Comparative pharmacology of human beta-adrenergic receptor subtypes\u2013characterization of stably transfected receptors in CHO cells. Naunyn Schmiedebergs Arch Pharmacol 369:151\u2013159. https:\/\/doi.org\/10.1007\/s00210-003-0860-y","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"966_CR31","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1002\/ejhf.826","volume":"19","author":"JS Hulot","year":"2017","unstructured":"Hulot JS, Salem JE, Redheuil A, Collet JP, Varnous S, Jourdain P, Logeart D, Gandjbakhch E, Bernard C, Hatem SN, Isnard R, Cluzel P, Le Feuvre C, Leprince P, Hammoudi N, Lemoine FM, Klatzmann D, Vicaut E, Komajda M, Montalescot G, Lompre AM, Hajjar RJ, Investigators A-H (2017) Effect of intracoronary administration of AAV1\/SERCA2a on ventricular remodelling in patients with advanced systolic heart failure: results from the AGENT-HF randomized phase 2 trial. Eur J Heart Fail 19:1534\u20131541. https:\/\/doi.org\/10.1002\/ejhf.826","journal-title":"Eur J Heart Fail"},{"key":"966_CR32","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.cardfail.2009.01.013S1071-9164(09)00035-9[pii]","volume":"15","author":"BE Jaski","year":"2009","unstructured":"Jaski BE, Jessup ML, Mancini DM, Cappola TP, Pauly DF, Greenberg B, Borow K, Dittrich H, Zsebo KM, Hajjar RJ, Up-Regulation C, by Percutaneous Administration of Gene Therapy In Cardiac Disease Trial I, (2009) Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1\/2 clinical trial. J Card Fail 15:171\u2013181. https:\/\/doi.org\/10.1016\/j.cardfail.2009.01.013S1071-9164(09)00035-9[pii]","journal-title":"J Card Fail"},{"key":"966_CR33","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1161\/CIRCULATIONAHA.111.022889","volume":"124","author":"M Jessup","year":"2011","unstructured":"Jessup M, Greenberg B, Mancini D, Cappola T, Pauly DF, Jaski B, Yaroshinsky A, Zsebo KM, Dittrich H, Hajjar RJ (2011) Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure. Circulation 124:304\u2013313. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.022889","journal-title":"Circulation"},{"key":"966_CR34","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1101\/gad.1124803","volume":"17","author":"K Jiao","year":"2003","unstructured":"Jiao K, Kulessa H, Tompkins K, Zhou Y, Batts L, Baldwin HS, Hogan BL (2003) An essential role of Bmp4 in the atrioventricular septation of the mouse heart. Genes Dev 17:2362\u20132367. https:\/\/doi.org\/10.1101\/gad.1124803","journal-title":"Genes Dev"},{"key":"966_CR35","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1161\/CIRCHEARTFAILURE.109.888479","volume":"3","author":"T Kato","year":"2010","unstructured":"Kato T, Niizuma S, Inuzuka Y, Kawashima T, Okuda J, Tamaki Y, Iwanaga Y, Narazaki M, Matsuda T, Soga T, Kita T, Kimura T, Shioi T (2010) Analysis of metabolic remodeling in compensated left ventricular hypertrophy and heart failure. Circ Heart Fail 3:420\u2013430. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.109.888479","journal-title":"Circ Heart Fail"},{"key":"966_CR36","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1161\/hc4501.098933","volume":"104","author":"TA Kohout","year":"2001","unstructured":"Kohout TA, Takaoka H, McDonald PH, Perry SJ, Mao L, Lefkowitz RJ, Rockman HA (2001) Augmentation of cardiac contractility mediated by the human beta(3)-adrenergic receptor overexpressed in the hearts of transgenic mice. Circulation 104:2485\u20132491. https:\/\/doi.org\/10.1161\/hc4501.098933","journal-title":"Circulation"},{"key":"966_CR37","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1161\/CIRCRESAHA.112.268128","volume":"111","author":"SC Kolwicz Jr","year":"2012","unstructured":"Kolwicz SC Jr, Olson DP, Marney LC, Garcia-Menendez L, Synovec RE, Tian R (2012) Cardiac-specific deletion of acetyl CoA carboxylase 2 prevents metabolic remodeling during pressure-overload hypertrophy. Circ Res 111:728\u2013738. https:\/\/doi.org\/10.1161\/CIRCRESAHA.112.268128","journal-title":"Circ Res"},{"key":"966_CR38","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1161\/CIRCRESAHA.113.302095","volume":"113","author":"SC Kolwicz Jr","year":"2013","unstructured":"Kolwicz SC Jr, Purohit S, Tian R (2013) Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes. Circ Res 113:603\u2013616. https:\/\/doi.org\/10.1161\/CIRCRESAHA.113.302095","journal-title":"Circ Res"},{"key":"966_CR39","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1093\/cvr\/cvr071","volume":"90","author":"SC Kolwicz Jr","year":"2011","unstructured":"Kolwicz SC Jr, Tian R (2011) Glucose metabolism and cardiac hypertrophy. Cardiovasc Res 90:194\u2013201. https:\/\/doi.org\/10.1093\/cvr\/cvr071","journal-title":"Cardiovasc Res"},{"key":"966_CR40","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1161\/CIRCRESAHA.113.300308","volume":"113","author":"A Lymperopoulos","year":"2013","unstructured":"Lymperopoulos A, Rengo G, Koch WJ (2013) Adrenergic nervous system in heart failure: pathophysiology and therapy. Circ Res 113:739\u2013753. https:\/\/doi.org\/10.1161\/CIRCRESAHA.113.300308","journal-title":"Circ Res"},{"key":"966_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.recesp.2019.02.024","author":"martinez-Milla J, Raposeiras-Roubin","year":"2019","unstructured":"martinez-Milla J, Raposeiras-Roubin S, Pascual-Figal D, B i, (2019) Role of beta-blockers in cardiovascular disease in 2019. Rev Esp Cardiol (In Press). https:\/\/doi.org\/10.1016\/j.recesp.2019.02.024","journal-title":"Rev Esp Cardiol (In Press)"},{"key":"966_CR42","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1126\/science.8160017","volume":"264","author":"CA Milano","year":"1994","unstructured":"Milano CA, Allen LF, Rockman HA, Dolber PC, McMinn TR, Chien KR, Johnson TD, Bond RA, Lefkowitz RJ (1994) Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor. Science 264:582\u2013586. https:\/\/doi.org\/10.1126\/science.8160017","journal-title":"Science"},{"key":"966_CR43","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1159\/000491916","volume":"48","author":"S Milano","year":"2018","unstructured":"Milano S, Gerbino A, Schena G, Carmosino M, Svelto M, Procino G (2018) Human beta3-adrenoreceptor is resistant to agonist-induced desensitization in renal epithelial cells. Cell Physiol Biochem 48:847\u2013862. https:\/\/doi.org\/10.1159\/000491916","journal-title":"Cell Physiol Biochem"},{"key":"966_CR44","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.bbrc.2008.01.017","volume":"367","author":"M Mitsuishi","year":"2008","unstructured":"Mitsuishi M, Miyashita K, Itoh H (2008) cGMP rescues mitochondrial dysfunction induced by glucose and insulin in myocytes. Biochem Biophys Res Commun 367:840\u2013845. https:\/\/doi.org\/10.1016\/j.bbrc.2008.01.017","journal-title":"Biochem Biophys Res Commun"},{"key":"966_CR45","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.yjmcc.2009.06.005","volume":"47","author":"AL Moens","year":"2009","unstructured":"Moens AL, Leyton-Mange JS, Niu X, Yang R, Cingolani O, Arkenbout EK, Champion HC, Bedja D, Gabrielson KL, Chen J, Xia Y, Hale AB, Channon KM, Halushka MK, Barker N, Wuyts FL, Kaminski PM, Wolin MS, Kass DA, Barouch LA (2009) Adverse ventricular remodeling and exacerbated NOS uncoupling from pressure-overload in mice lacking the beta3-adrenoreceptor. J Mol Cell Cardiol 47:576\u2013585. https:\/\/doi.org\/10.1016\/j.yjmcc.2009.06.005","journal-title":"J Mol Cell Cardiol"},{"key":"966_CR46","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1161\/01.cir.103.12.1649","volume":"103","author":"S Moniotte","year":"2001","unstructured":"Moniotte S, Kobzik L, Feron O, Trochu JN, Gauthier C, Balligand JL (2001) Upregulation of beta(3)-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium. Circulation 103:1649\u20131655. https:\/\/doi.org\/10.1161\/01.cir.103.12.1649","journal-title":"Circulation"},{"key":"966_CR47","doi-asserted-by":"publisher","first-page":"H2425","DOI":"10.1152\/ajpheart.01045.2003","volume":"286","author":"A Morimoto","year":"2004","unstructured":"Morimoto A, Hasegawa H, Cheng HJ, Little WC, Cheng CP (2004) Endogenous beta3-adrenoreceptor activation contributes to left ventricular and cardiomyocyte dysfunction in heart failure. Am J Physiol Heart Circ Physiol 286:H2425-2433. https:\/\/doi.org\/10.1152\/ajpheart.01045.2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"966_CR48","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jacc.2017.03.011","volume":"70","author":"RA Nishimura","year":"2017","unstructured":"Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Fleisher LA, Jneid H, Mack MJ, McLeod CJ, O\u2019Gara PT, Rigolin VH, Sundt TM 3rd, Thompson A (2017) 2017 AHA\/ACC focused update of the 2014 AHA\/ACC Guideline for the management of patients with valvular heart disease: a report of the american college of cardiology\/american heart association task force on clinical practice guidelines. J Am Coll Cardiol 70:252\u2013289. https:\/\/doi.org\/10.1016\/j.jacc.2017.03.011","journal-title":"J Am Coll Cardiol"},{"key":"966_CR49","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1016\/j.jacc.2011.12.046","volume":"59","author":"X Niu","year":"2012","unstructured":"Niu X, Watts VL, Cingolani OH, Sivakumaran V, Leyton-Mange JS, Ellis CL, Miller KL, Vandegaer K, Bedja D, Gabrielson KL, Paolocci N, Kass DA, Barouch LA (2012) Cardioprotective effect of beta-3 adrenergic receptor agonism: role of neuronal nitric oxide synthase. J Am Coll Cardiol 59:1979\u20131987. https:\/\/doi.org\/10.1016\/j.jacc.2011.12.046","journal-title":"J Am Coll Cardiol"},{"key":"966_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098713","volume":"9","author":"X Niu","year":"2014","unstructured":"Niu X, Zhao L, Li X, Xue Y, Wang B, Lv Z, Chen J, Sun D, Zheng Q (2014) beta3-Adrenoreceptor stimulation protects against myocardial infarction injury via eNOS and nNOS activation. PLoS ONE 9:e98713. https:\/\/doi.org\/10.1371\/journal.pone.0098713","journal-title":"PLoS ONE"},{"key":"966_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.rec.2019.04.006","author":"E Oliver","year":"2019","unstructured":"Oliver E, Mayor F Jr, D\u2019Ocon P (2019) Beta-blockers: Historical perspective and mechanisms of action. Rev Esp Cardiol (Engl Ed). https:\/\/doi.org\/10.1016\/j.rec.2019.04.006","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"966_CR52","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1161\/01.cir.0000023531.22727.c1","volume":"106","author":"JC Osorio","year":"2002","unstructured":"Osorio JC, Stanley WC, Linke A, Castellari M, Diep QN, Panchal AR, Hintze TH, Lopaschuk GD, Recchia FA (2002) Impaired myocardial fatty acid oxidation and reduced protein expression of retinoid X receptor-alpha in pacing-induced heart failure. Circulation 106:606\u2013612. https:\/\/doi.org\/10.1161\/01.cir.0000023531.22727.c1","journal-title":"Circulation"},{"key":"966_CR53","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1161\/01.RES.0000237661.18885.f6","volume":"99","author":"CA Pacak","year":"2006","unstructured":"Pacak CA, Mah CS, Thattaliyath BD, Conlon TJ, Lewis MA, Cloutier DE, Zolotukhin I, Tarantal AF, Byrne BJ (2006) Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo. Circ Res 99:e3-9. https:\/\/doi.org\/10.1161\/01.RES.0000237661.18885.f6","journal-title":"Circ Res"},{"key":"966_CR54","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1038\/nprot.2008.138","volume":"3","author":"P Pacher","year":"2008","unstructured":"Pacher P, Nagayama T, Mukhopadhyay P, Batkai S, Kass DA (2008) Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats. Nat Protoc 3:1422\u20131434. https:\/\/doi.org\/10.1038\/nprot.2008.138","journal-title":"Nat Protoc"},{"key":"966_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/cells10030535","author":"N Pavlaki","year":"2021","unstructured":"Pavlaki N, De Jong KA, Geertz B, Nikolaev VO, Froese A (2021) Cardiac hypertrophy changes compartmentation of cAMP in non-raft membrane microdomains. Cells. https:\/\/doi.org\/10.3390\/cells10030535","journal-title":"Cells"},{"key":"966_CR56","doi-asserted-by":"crossref","unstructured":"Pleger ST, Most P, Boucher M, Soltys S, Chuprun JK, Pleger W, Gao E, Dasgupta A, Rengo G, Remppis A, Katus HA, Eckhart AD, Rabinowitz JE, Koch WJ (2007) Stable myocardial-specific AAV6-S100A1 gene therapy results in chronic functional heart failure rescue. Circulation 115:2506\u20132515 CIRCULATIONAHA.106.671701","DOI":"10.1161\/CIRCULATIONAHA.106.671701"},{"key":"966_CR57","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.ymthe.2005.08.002","volume":"12","author":"ST Pleger","year":"2005","unstructured":"Pleger ST, Remppis A, Heidt B, Volkers M, Chuprun JK, Kuhn M, Zhou RH, Gao E, Szabo G, Weichenhan D, Muller OJ, Eckhart AD, Katus HA, Koch WJ, Most P (2005) S100A1 gene therapy preserves in vivo cardiac function after myocardial infarction. Mol Ther 12:1120\u20131129. https:\/\/doi.org\/10.1016\/j.ymthe.2005.08.002","journal-title":"Mol Ther"},{"key":"966_CR58","doi-asserted-by":"publisher","unstructured":"Pleger ST, Shan C, Ksienzyk J, Bekeredjian R, Boekstegers P, Hinkel R, Schinkel S, Leuchs B, Ludwig J, Qiu G, Weber C, Raake P, Koch WJ, Katus HA, Muller OJ, Most P (2011) Cardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal model. Sci Transl Med 3:92ra64 https:\/\/doi.org\/10.1126\/scitranslmed.3002097","DOI":"10.1126\/scitranslmed.3002097"},{"key":"966_CR59","doi-asserted-by":"publisher","first-page":"24103","DOI":"10.1016\/s0021-9258(18)35952-0","volume":"267","author":"JD Port","year":"1992","unstructured":"Port JD, Huang LY, Malbon CC (1992) Beta-adrenergic agonists that down-regulate receptor mRNA up-regulate a M(r) 35,000 protein(s) that selectively binds to beta-adrenergic receptor mRNAs. J Biol Chem 267:24103\u201324108. https:\/\/doi.org\/10.1016\/s0021-9258(18)35952-0","journal-title":"J Biol Chem"},{"key":"966_CR60","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1002\/ehf2.12306","volume":"5","author":"AC Pouleur","year":"2018","unstructured":"Pouleur AC, Anker S, Brito D, Brosteanu O, Hasenclever D, Casadei B, Edelmann F, Filippatos G, Gruson D, Ikonomidis I, Lhommel R, Mahmod M, Neubauer S, Persu A, Gerber BL, Piechnik S, Pieske B, Pieske-Kraigher E, Pinto F, Ponikowski P, Senni M, Trochu JN, Van Overstraeten N, Wachter R, Balligand JL (2018) Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3-left ventricular hypertrophy (Beta3-LVH). ESC Heart Fail 5:830\u2013841. https:\/\/doi.org\/10.1002\/ehf2.12306","journal-title":"ESC Heart Fail"},{"key":"966_CR61","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41419-018-0442-z","volume":"9","author":"B Prados","year":"2018","unstructured":"Prados B, Gomez-Apinaniz P, Papoutsi T, Luxan G, Zaffran S, Perez-Pomares JM, de la Pompa JL (2018) Myocardial Bmp2 gain causes ectopic EMT and promotes cardiomyocyte proliferation and immaturity. Cell Death Dis 9:399. https:\/\/doi.org\/10.1038\/s41419-018-0442-z","journal-title":"Cell Death Dis"},{"key":"966_CR62","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00395-022-00936-5","volume":"117","author":"C Quast","year":"2022","unstructured":"Quast C, Kober F, Becker K, Zweck E, Hoffe J, Jacoby C, Flocke V, Gyamfi-Poku I, Keyser F, Piayda K, Erkens R, Niepmann S, Adam M, Baldus S, Zimmer S, Nickenig G, Grandoch M, Bonner F, Kelm M, Flogel U (2022) Multiparametric MRI identifies subtle adaptations for demarcation of disease transition in murine aortic valve stenosis. Basic Res Cardiol 117:29. https:\/\/doi.org\/10.1007\/s00395-022-00936-5","journal-title":"Basic Res Cardiol"},{"key":"966_CR63","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1111\/j.1476-5381.2012.01954.x","volume":"166","author":"G Rengo","year":"2012","unstructured":"Rengo G, Zincarelli C, Femminella GD, Liccardo D, Pagano G, de Lucia C, Altobelli GG, Cimini V, Ruggiero D, Perrone-Filardi P, Gao E, Ferrara N, Lymperopoulos A, Koch WJ, Leosco D (2012) Myocardial beta(2) -adrenoceptor gene delivery promotes coordinated cardiac adaptive remodelling and angiogenesis in heart failure. Br J Pharmacol 166:2348\u20132361. https:\/\/doi.org\/10.1111\/j.1476-5381.2012.01954.x","journal-title":"Br J Pharmacol"},{"key":"966_CR64","doi-asserted-by":"publisher","first-page":"8277","DOI":"10.1073\/pnas.88.18.8277","volume":"88","author":"HA Rockman","year":"1991","unstructured":"Rockman HA, Ross RS, Harris AN, Knowlton KU, Steinhelper ME, Field LJ, Ross J Jr, Chien KR (1991) Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc Natl Acad Sci USA 88:8277\u20138281. https:\/\/doi.org\/10.1073\/pnas.88.18.8277","journal-title":"Proc Natl Acad Sci USA"},{"key":"966_CR65","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/ncb2740","volume":"15","author":"M Rosenwald","year":"2013","unstructured":"Rosenwald M, Perdikari A, Rulicke T, Wolfrum C (2013) Bi-directional interconversion of brite and white adipocytes. Nat Cell Biol 15:659\u2013667. https:\/\/doi.org\/10.1038\/ncb2740","journal-title":"Nat Cell Biol"},{"key":"966_CR66","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s10557-018-6805-y","volume":"32","author":"HN Sabbah","year":"2018","unstructured":"Sabbah HN, Gupta RC, Singh-Gupta V, Zhang K, Lanfear DE (2018) Abnormalities of mitochondrial dynamics in the failing heart: normalization following long-term therapy with elamipretide. Cardiovasc Drugs Ther 32:319\u2013328. https:\/\/doi.org\/10.1007\/s10557-018-6805-y","journal-title":"Cardiovasc Drugs Ther"},{"key":"966_CR67","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.52221","author":"S Schobesberger","year":"2020","unstructured":"Schobesberger S, Wright PT, Poulet C, Sanchez Alonso Mardones JL, Mansfield C, Friebe A, Harding SE, Balligand JL, Nikolaev VO, Gorelik J (2020) beta3-Adrenoceptor redistribution impairs NO\/cGMP\/PDE2 signalling in failing cardiomyocytes. Elife. https:\/\/doi.org\/10.7554\/eLife.52221","journal-title":"Elife"},{"key":"966_CR68","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.jacc.2010.09.037","volume":"57","author":"SA Sorrentino","year":"2011","unstructured":"Sorrentino SA, Doerries C, Manes C, Speer T, Dessy C, Lobysheva I, Mohmand W, Akbar R, Bahlmann F, Besler C, Schaefer A, Hilfiker-Kleiner D, Luscher TF, Balligand JL, Drexler H, Landmesser U (2011) Nebivolol exerts beneficial effects on endothelial function, early endothelial progenitor cells, myocardial neovascularization, and left ventricular dysfunction early after myocardial infarction beyond conventional beta1-blockade. J Am Coll Cardiol 57:601\u2013611. https:\/\/doi.org\/10.1016\/j.jacc.2010.09.037","journal-title":"J Am Coll Cardiol"},{"key":"966_CR69","doi-asserted-by":"publisher","first-page":"29483","DOI":"10.1074\/jbc.270.49.29483","volume":"270","author":"VS Susulic","year":"1995","unstructured":"Susulic VS, Frederich RC, Lawitts J, Tozzo E, Kahn BB, Harper ME, Himms-Hagen J, Flier JS, Lowell BB (1995) Targeted disruption of the beta 3-adrenergic receptor gene. J Biol Chem 270:29483\u201329492. https:\/\/doi.org\/10.1074\/jbc.270.49.29483","journal-title":"J Biol Chem"},{"key":"966_CR70","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/s0008-6363(03)00359-6","volume":"59","author":"G Tavernier","year":"2003","unstructured":"Tavernier G, Toumaniantz G, Erfanian M, Heymann MF, Laurent K, Langin D, Gauthier C (2003) beta3-Adrenergic stimulation produces a decrease of cardiac contractility ex vivo in mice overexpressing the human beta3-adrenergic receptor. Cardiovasc Res 59:288\u2013296. https:\/\/doi.org\/10.1016\/s0008-6363(03)00359-6","journal-title":"Cardiovasc Res"},{"key":"966_CR71","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/gene.20095","volume":"40","author":"K Vintersten","year":"2004","unstructured":"Vintersten K, Monetti C, Gertsenstein M, Zhang P, Laszlo L, Biechele S, Nagy A (2004) Mouse in red: red fluorescent protein expression in mouse ES cells, embryos, and adult animals. Genesis 40:241\u2013246. https:\/\/doi.org\/10.1002\/gene.20095","journal-title":"Genesis"},{"key":"966_CR72","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad0116","author":"T Wai","year":"2015","unstructured":"Wai T, Garcia-Prieto J, Baker MJ, Merkwirth C, Benit P, Rustin P, Ruperez FJ, Barbas C, Ibanez B, Langer T (2015) Imbalanced OPA1 processing and mitochondrial fragmentation cause heart failure in mice. Science. https:\/\/doi.org\/10.1126\/science.aad0116","journal-title":"Science"},{"key":"966_CR73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0179648","volume":"12","author":"B Wang","year":"2017","unstructured":"Wang B, Xu M, Li W, Li X, Zheng Q, Niu X (2017) Aerobic exercise protects against pressure overload-induced cardiac dysfunction and hypertrophy via beta3-AR-nNOS-NO activation. PLoS One 12:e0179648. https:\/\/doi.org\/10.1371\/journal.pone.0179648","journal-title":"PLoS One"},{"key":"966_CR74","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1124\/jpet.113.208017","volume":"347","author":"RM Whitaker","year":"2013","unstructured":"Whitaker RM, Wills LP, Stallons LJ, Schnellmann RG (2013) cGMP-selective phosphodiesterase inhibitors stimulate mitochondrial biogenesis and promote recovery from acute kidney injury. J Pharmacol Exp Ther 347:626\u2013634. https:\/\/doi.org\/10.1124\/jpet.113.208017","journal-title":"J Pharmacol Exp Ther"},{"key":"966_CR75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098179","volume":"9","author":"Z Zhang","year":"2014","unstructured":"Zhang Z, Ding L, Jin Z, Gao G, Li H, Zhang L, Zhang L, Lu X, Hu L, Lu B, Yu X, Hu T (2014) Nebivolol protects against myocardial infarction injury via stimulation of beta 3-adrenergic receptors and nitric oxide signaling. PLoS ONE 9:e98179. https:\/\/doi.org\/10.1371\/journal.pone.0098179","journal-title":"PLoS ONE"},{"key":"966_CR76","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.hrthm.2007.10.014","volume":"5","author":"S Zhou","year":"2008","unstructured":"Zhou S, Tan AY, Paz O, Ogawa M, Chou CC, Hayashi H, Nihei M, Fishbein MC, Chen LS, Lin SF, Chen PS (2008) Antiarrhythmic effects of beta3-adrenergic receptor stimulation in a canine model of ventricular tachycardia. Heart Rhythm 5:289\u2013297. https:\/\/doi.org\/10.1016\/j.hrthm.2007.10.014","journal-title":"Heart Rhythm"},{"key":"966_CR77","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1161\/CIRCRESAHA.113.302421","volume":"114","author":"K Zsebo","year":"2014","unstructured":"Zsebo K, Yaroshinsky A, Rudy JJ, Wagner K, Greenberg B, Jessup M, Hajjar RJ (2014) Long-term effects of AAV1\/SERCA2a gene transfer in patients with severe heart failure: analysis of recurrent cardiovascular events and mortality. Circ Res 114:101\u2013108. https:\/\/doi.org\/10.1161\/CIRCRESAHA.113.302421","journal-title":"Circ Res"}],"container-title":["Basic Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00395-022-00966-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00395-022-00966-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00395-022-00966-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T12:11:37Z","timestamp":1675080697000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00395-022-00966-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,29]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["966"],"URL":"https:\/\/doi.org\/10.1007\/s00395-022-00966-z","relation":{},"ISSN":["0300-8428","1435-1803"],"issn-type":[{"value":"0300-8428","type":"print"},{"value":"1435-1803","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,29]]},"assertion":[{"value":"19 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Nothing to declare. The author declare no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"62"}}